Abstract
Neat N-methyl-2-pyrrolidone (NMP) rapidly penetrated into the skin of male Sprague-Dawley rats after in vivo and in vitro topical application. At the two topical doses tested in vivo, no steady state was observed. The maximal absorption fluxes were 10 and 20 mg/cm2/h for 20 μl/cm2 and 40 μl/cm2, respectively. Similar results were observed after in vitro topical application of neat [14C]NMP (25–400 μl/cm2) in fresh full-thickness skin. Whatever the dose tested, the percutaneous absorption fluxes increased with exposure time to reach a maximum value (Fmax) and then decreased. Fmax and the time to reach it (Tmax) increased as the dose increased. At the highest dose, which may be considered as an “infinite dose,” the maximal flux (7.7 ± 1.1 mg/cm2/h, n= 12) occurred 6 h after the topical application of NMP. The decrease on percutaneous absorption flux was correlated with the dilution of neat NMP with water from the receptor fluid. A semi-quantitative mathematical model was developed to describe the absorption flux of NMP taking into account the transfer of water through the skin. The Kp values determined from the different aqueous solutions of NMP (1:1 to 1:32, v/v) were not significantly different. The mean value was 6.4 (10−3cm/h) (range, 4.7 to 7.6). Occlusion did not affect the percutaneous absorption flux of neat NMP. Desquamation increased the percutaneous absorption of NMP slightly. The skin did not metabolize NMP. The flux was dependent on the thickness of the skin and was proportional to the concentration of NMP. These findings suggest a passive diffusion of NMP through the skin.
Footnotes
-
This study was sponsored by Public Health Service Grant NCCAM R21 AT00511-01.
- Abbreviations used are::
- NMP
- N-methyl-2-pyrrolidone
- LD50
- 5-HNMP, 5-hydroxy-NMP
- HPLC
- high performance liquid chromatography
- ANOVA
- analysis of variance
- Fmax
- maximal percutaneous absorption flux
- Fmax Nor
- Fmax for a skin thickness of 1.3 mm
- AUC
- area under the plasma curves
- Received November 13, 2002.
- Accepted February 13, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|